Join us in person or online on Tuesday, March 28, 2017 as we release the fourth edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada.
This release marks the first update to the Guidelines since the third edition was published in 2006.
The Guidelines are intended to help produce credible and standardized economic i...
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.
1. Expanding CADTH’s Drug Review Processes to Include Radiopharmaceuticals
In collaboration with the participating jurisdictions, CADTH is pleased to announce that CADTH will accept submissions for radiopharmaceuticals used for therapeutic purposes (i.e., not for diagnostic purposes) for review through the CADTH Common Drug Review (CDR) and the ...
A report on New Drugs for Type 2 Diabetes: Second-Line Therapy : A Therapeutic Review Update is now available for feedback from all interested stakeholders.
Call for Feedback
Feedback Due By
New Drugs for Type 2 Diabetes: Second-Line Therapy : A Therapeutic Review Update
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.